Parametric Portfolio Associates’s CorMedix CRMD Stock Holding History

Parametric Portfolio Associates’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$93K	Sell	17,004 -17,632	-51%	-$80.7K	﹤0.01%	3574
2021 Q4	$158K	Buy	34,636 +16,848	+95%	+$83.6K	﹤0.01%	3467
2021 Q3	$83K	Buy	17,788 +4,012	+29%	+$23.4K	﹤0.01%	3549
2021 Q2	$95K	Buy	13,776 +946	+7%	+$7.53K	﹤0.01%	3490
2021 Q1	$128K	Buy	+12,830	New	+$135K	﹤0.01%	3944
2020 Q3	–	Sell	-10,041	Closed	-$63K	–	3936
2020 Q2	$63K	Buy	+10,041	New	+$46.5K	﹤0.01%	3841

Other funds holding CRMD

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Parametric Portfolio Associates's CRMD Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its CorMedix (CRMD) stake by 51% in Q1 2022, selling an estimated $80.7K and leaving 17,004 shares worth $93K. The position accounts for ﹤0.01% of the portfolio, ranked #3574.

Parametric Portfolio Associates first reported a position in CRMD in Q2 2020 and has held it in 6 quarters since. The position peaked at $158K in Q4 2021. 85 funds tracked by Wall St. Rank hold CRMD as of Q1 2022.

Parametric Portfolio Associates held 17,004 shares of CorMedix worth $93K as of Q1 2022.
Parametric Portfolio Associates sold 17,632 CorMedix shares in Q1 2022, an estimated $80.7K.
CorMedix made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3574 holding.
Parametric Portfolio Associates first reported a position in CorMedix in Q2 2020 and has held it in 6 quarters since.
Parametric Portfolio Associates's CorMedix position peaked at $158K in Q4 2021.
85 funds tracked by Wall St. Rank held CorMedix as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.